Fig 1: Expression levels of CCL2/CCR2 and CXCL1/CXCR2 are correlated with HCC progression in the HCC model. Sprague Dawley rats were treated with diethylnitrosamine. After 8, 12 or 14 weeks, the rats were sacrificed to observe the development of HCC. The expression levels of CCL2, CCR2, CXCL1, and CXCR2 proteins were detected by immunohistochemical analysis. As CXCL8 is absent in rodents, we examined CXCL1, which is considered the functional equivalent of human CXCL8 in promoting neutrophil migration. The integral optical density (IOD) of the stained sections was calculated, and then Pearson’s correlation analysis was performed to investigate the relationship between the protein expression level and diethylnitrosamine treatment time. Pearson’s correlation analysis yielded the correlation coefficient (r) and the p-value. A Representative images of CCL2, CCR2, CXCL1, and CXCR2 immunostaining in the liver tissue of rats after 8, 12 and 14 weeks of diethylnitrosamine treatment. Asterisks indicate positive staining. Scale bar 200 μm. (B-E) Pearson's correlation analysis between B CCL2 and diethylnitrosamine treatment time (r = 0.70, p < 0.0001), C CCR2 and diethylnitrosamine treatment time (r = 0.74, p < 0.0001), D CXCL1 and diethylnitrosamine treatment time (r = 0.67, p < 0.0001), and E CCR2 and diethylnitrosamine treatment time (r = 0.71, p < 0.0001)
Fig 2: The expression of CCL2 (a) and CXCL8 (b) mRNA in rat endometrium on D6, D8, and D10 of pregnancy. Relative quantitation of CCL2 and CXCL8 expression was determined by the ratio to β-actin expression. Results were represented as means ± SD (n = 6). *P < 0.05, **P < 0.01 compared with N; # P < 0.05, ## P < 0.01 compared with M.
Fig 3: Single nucleus profile of iHNOs corresponds with their fibroblasts of origin.a Proportion plots to demonstrate the identified sub-populations in iHNO epithelium and mesenchyme. Cycling TA = cycling transient amplifying cells; Myo FB = myofibroblasts; PC venules = pericyte venules. b Proportion plots illustrating sub-populations per cell type in iHUCOs. Cycling TA = cycling transient amplifying cells; I. enterocyte = immature enterocytes; I. goblet = immature goblet cells; Myo FB = myofibroblasts; cycling B = cycling B cells; NK = natural killer cells. c–f Representative IHC for HLA-A-expressing and Limch1-expressing epithelia in iHNO vs. iHUCO with violin plots showing a significant increase in expression of both proteins in iHUCOs compared with iHNOs. The unpaired, non-parametric two-sided Mann–Whitney U test was used to test for the difference in percentages between iHNO and iHUCO. Scale bar = 40 μm. n = 5 iHNOs (blue) and n = 6 iHUCOs (orange). g Representative cytokine arrays of normal and UC parental fibroblasts and organoid-derived mesenchyme with the quantification of three chemokines are increased in UC vs. normal: GRO-α (green), GRO − α + β + γ (blue), and CXCL8 (orange). The median value is indicated in the center of the box plot. The whiskers above and below the plot represent 1 standard deviation (SD) above and below the mean of the data, respectively. Source data are provided as a Source Data file.
Fig 4: IFS of fibronectin (green) and nucleus (blue) (A,B); scale bar 10 µm; red arrow redistributed fibronectin, qPCR analyses of FN1 (C), Col1A1 (E), Col4A5 (F), SPP1 (H), TGB1 (J), TIMP1 (K), MMP1 (L), MMP3 (M), MMP14 (N), IL-6 (O), CXCL8 (P) and LOX (R), and WB of fibronectin (D), collagen IV (G), osteopontin (I), and IL-8 (Q). “TX53” indicates samples collected from the sounding rocket mission, whereas “Hyper-g” presents data from a parallel experiment simulating the worst case-possible launch acceleration. IF: in-flight; Con: control; Sim: simulated; RPM: random positioning machine; 6min s-µg; * p < 0.05 vs.1g.
Fig 5: High expression levels of CCL2/CCR2 and CXCL8/CXCR2 in HCC specimens are associated with poor prognosis. Kaplan–Meier estimated of overall survival in 74 patients with HCC according to the expression level of CCL2, CCR2, CXCL8 and CXCR2 in immunohistochemical. Images of five randomly chosen fields per slide were taken with a microscope. Image-Pro Plus 6.2 was employed to analyse the levels of protein expression by calculating the values of mean integrated optical density (integrated optical density/area) for statistical analysis. Patients were divided into low- and high-expression groups by the median of mean integrated optical density. A Four representative images of CCL2 immunostaining in clinical HCC specimens. B, C The Kaplan–Meier curves for disease-free survival (DFS) and overall survival (OS) of this cohort according to low and high expression of CCL2. D Four representative images of CCR2 immunostaining in clinical HCC specimens. E–F Kaplan–Meier curves for DFS and OS according to the expression levels of CCR2. G Four representative images of CXCL8 immunostaining in clinical HCC specimens. H–I Kaplan–Meier DFS and OS curves according to the expression levels of CXCL8. J Four representative images of CXCR2 immunostaining in clinical HCC specimens. K–L Kaplan–Meier DFS and OS curves according to the expression levels of CXCR2. The log-rank p-value for Kaplan–Meier curve is shown on the Kaplan–Meier curve plot. p < 0.05 was considered as statistically significant. Scale bar, 200 μm
Supplier Page from Abcam for Anti-IL-8 antibody